These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 24244308)
1. Stability of transmembrane amyloid β-peptide and membrane integrity tested by molecular modeling of site-specific Aβ42 mutations. Poojari C; Strodel B PLoS One; 2013; 8(11):e78399. PubMed ID: 24244308 [TBL] [Abstract][Full Text] [Related]
2. Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding. Xu L; Chen Y; Wang X Proteins; 2014 Dec; 82(12):3286-97. PubMed ID: 25137638 [TBL] [Abstract][Full Text] [Related]
3. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system. Tackenberg C; Kulic L; Nitsch RM PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331 [TBL] [Abstract][Full Text] [Related]
4. Neurotoxicity and physicochemical properties of Abeta mutant peptides from cerebral amyloid angiopathy: implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease. Murakami K; Irie K; Morimoto A; Ohigashi H; Shindo M; Nagao M; Shimizu T; Shirasawa T J Biol Chem; 2003 Nov; 278(46):46179-87. PubMed ID: 12944403 [TBL] [Abstract][Full Text] [Related]
5. On the role of sidechain size and charge in the aggregation of A Yang X; Meisl G; Frohm B; Thulin E; Knowles TPJ; Linse S Proc Natl Acad Sci U S A; 2018 Jun; 115(26):E5849-E5858. PubMed ID: 29895690 [TBL] [Abstract][Full Text] [Related]
6. Point mutations in Aβ result in the formation of distinct polymorphic aggregates in the presence of lipid bilayers. Pifer PM; Yates EA; Legleiter J PLoS One; 2011 Jan; 6(1):e16248. PubMed ID: 21267410 [TBL] [Abstract][Full Text] [Related]
7. Probing structural features of Alzheimer's amyloid-β pores in bilayers using site-specific amino acid substitutions. Capone R; Jang H; Kotler SA; Kagan BL; Nussinov R; Lal R Biochemistry; 2012 Jan; 51(3):776-85. PubMed ID: 22242635 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the secondary structure of beta-amyloid (Abeta42) fibrils by systematic proline replacement. Morimoto A; Irie K; Murakami K; Masuda Y; Ohigashi H; Nagao M; Fukuda H; Shimizu T; Shirasawa T J Biol Chem; 2004 Dec; 279(50):52781-8. PubMed ID: 15459202 [TBL] [Abstract][Full Text] [Related]
9. The structures of the E22Δ mutant-type amyloid-β alloforms and the impact of E22Δ mutation on the structures of the wild-type amyloid-β alloforms. Coskuner O; Wise-Scira O; Perry G; Kitahara T ACS Chem Neurosci; 2013 Feb; 4(2):310-20. PubMed ID: 23421682 [TBL] [Abstract][Full Text] [Related]
10. Effect of alanine replacement of l17 and f19 on the aggregation and neurotoxicity of arctic-type aβ40. Chen YR; Huang HB; Lo CJ; Wang CC; Ho LK; Liu HT; Shiao MS; Lin TH; Chen YC PLoS One; 2013; 8(4):e61874. PubMed ID: 23634215 [TBL] [Abstract][Full Text] [Related]
11. Molecular interactions of Alzheimer amyloid-β oligomers with neutral and negatively charged lipid bilayers. Yu X; Wang Q; Pan Q; Zhou F; Zheng J Phys Chem Chem Phys; 2013 Jun; 15(23):8878-89. PubMed ID: 23493873 [TBL] [Abstract][Full Text] [Related]
12. E22G Aβ40 fibril structure and kinetics illuminate how Aβ40 rather than Aβ42 triggers familial Alzheimer's. Tehrani MJ; Matsuda I; Yamagata A; Kodama Y; Matsunaga T; Sato M; Toyooka K; McElheny D; Kobayashi N; Shirouzu M; Ishii Y Nat Commun; 2024 Aug; 15(1):7045. PubMed ID: 39147751 [TBL] [Abstract][Full Text] [Related]
13. Toxicity inhibitors protect lipid membranes from disruption by Aβ42. Malishev R; Nandi S; Kolusheva S; Levi-Kalisman Y; Klärner FG; Schrader T; Bitan G; Jelinek R ACS Chem Neurosci; 2015 Nov; 6(11):1860-9. PubMed ID: 26317327 [TBL] [Abstract][Full Text] [Related]
14. Free energy of lipid bilayer defects affected by Alzheimer's disease-associated amyloid-β42 monomers. Pobandt T; Knecht V J Phys Chem B; 2014 Apr; 118(13):3507-16. PubMed ID: 24597727 [TBL] [Abstract][Full Text] [Related]
15. Structural heterogeneity in familial Alzheimer's disease mutants of amyloid-beta peptides. Chong SH; Yim J; Ham S Mol Biosyst; 2013 May; 9(5):997-1003. PubMed ID: 23358498 [TBL] [Abstract][Full Text] [Related]
16. Aggregation and catabolism of disease-associated intra-Abeta mutations: reduced proteolysis of AbetaA21G by neprilysin. Betts V; Leissring MA; Dolios G; Wang R; Selkoe DJ; Walsh DM Neurobiol Dis; 2008 Sep; 31(3):442-50. PubMed ID: 18602473 [TBL] [Abstract][Full Text] [Related]
17. Generic hydrophobic residues are sufficient to promote aggregation of the Alzheimer's Abeta42 peptide. Kim W; Hecht MH Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15824-9. PubMed ID: 17038501 [TBL] [Abstract][Full Text] [Related]
18. Binding of β-amyloid (1-42) peptide to negatively charged phospholipid membranes in the liquid-ordered state: modeling and experimental studies. Ahyayauch H; Raab M; Busto JV; Andraka N; Arrondo JR; Masserini M; Tvaroska I; Goñi FM Biophys J; 2012 Aug; 103(3):453-463. PubMed ID: 22947861 [TBL] [Abstract][Full Text] [Related]
19. Structural progression of amyloid-β Arctic mutant aggregation in cells revealed by multiparametric imaging. Lu M; Williamson N; Mishra A; Michel CH; Kaminski CF; Tunnacliffe A; Kaminski Schierle GS J Biol Chem; 2019 Feb; 294(5):1478-1487. PubMed ID: 30504224 [TBL] [Abstract][Full Text] [Related]
20. G37V mutation of Aβ42 induces a nontoxic ellipse-like aggregate: An in vitro and in silico study. Minh Thu TT; Huang SH; Tu LA; Fang ST; Li MS; Chen YC Neurochem Int; 2019 Oct; 129():104512. PubMed ID: 31374231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]